NDC 50881-010-60
JAKAFI 10 mg/1
ruxolitinib · TABLET
JAKAFI is a tablet containing ruxolitinib at a strength of 10 mg/1. Manufactured by Incyte Corporation.
Key Facts
- Brand Name
- JAKAFI
- Generic Name
- ruxolitinib
- NDC Code (Package)
50881-010-60- NDC Code (Product)
50881-010- Manufacturer
- Incyte Corporation
- Strength
- 10 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA202192
- Drug Class
- Kinase Inhibitor [EPC]; Janus Kinase Inhibitor [EPC]
- Marketing Start
- 11/16/2011
Recall History
No Recall HistoryView Full Drug Page
JAKAFI — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.